Domů › Rakovina vaječníků › Colorado › Aurora
Klinické studie Rakovina vaječníků v Aurora, CO
25 studií pro Rakovina vaječníků hledá účastníky v lokalitách v Aurora a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Probíhá náborFáze 2/3
- UCHealth University of Colorado Hospital, Aurora
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Probíhá náborFáze 2
- UCHealth University of Colorado Hospital, Aurora
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Probíhá náborFáze 1/2
- Research Site, Aurora
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Probíhá náborFáze 2
- University of Colorado Hospital- Aurora /ID# 278232, Aurora
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Probíhá náborFáze 1/2
- University of Colorado Denver, Aurora
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Probíhá náborFáze 3
- Anschutz Cancer Pavilion, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Probíhá náborFáze 1/2
- University of Colorado Cancer Center, Aurora
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Probíhá náborFáze 1
- University of Colorado Cancer Center, Aurora
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Probíhá náborFáze 3
- University of Colorado Cancer Center, Aurora
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Probíhá náborObservační studie
- University of Colorado, Aurora
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Probíhá náborFáze 1
- Outpatient CTRC, Aurora
- University of Colorado Cancer Center, Aurora
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Probíhá náborFáze 1/2
- Children's Hospital Colorado, Aurora
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Probíhá nábor
- UCHealth University of Colorado Hospital, Aurora
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Probíhá náborFáze 3
- UCHealth University of Colorado Hospital, Aurora
Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer
Probíhá náborFáze 1
- CU Medicine Clinics, Aurora
- Universtiy of Colorado Hospital, Aurora
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Probíhá náborFáze 2
- University of Colorado Hospital, Aurora
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- University of Colorado Cancer Center, Aurora
The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
Probíhá nábor
- University of Colorado Anschutz Medical Campus, Aurora
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Probíhá náborFáze 1/2
- University of Colorado, Anschutz Medical Campus, Aurora
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Probíhá náborFáze 3
- University of Colorado Hospital - Anshutz Cancer Pavilion, Aurora
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
Probíhá nábor
- University of Colorado Cancer Center-Anschutz, Aurora
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
Probíhá náborFáze 1
- Site 0264, Aurora
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
Probíhá náborFáze 1
- University of Colorado Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Aurora
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
Probíhá nábor
- University of Colorado, Aurora
Studie Rakovina vaječníků v jiných městech
- Houston, TX89 studií
- New York City, NY69 studií
- Boston, MA61 studií
- Los Angeles, CA50 studií
- Nashville, TN49 studií
- Arlington, VA46 studií
- Philadelphia, PA44 studií
- Columbus, OH39 studií
- St. Louis, MO38 studií
- Chicago, IL36 studií
- San Antonio, TX31 studií
- Cleveland, OH30 studií
Další studie v Aurora
- Rakovina (všechny typy)35 studií
- Kolorektální karcinom32 studií
- Nemalobuněčný plicní karcinom31 studií
- Rakovina prsu28 studií
- Metastatický karcinom25 studií
- Diabetes mellitus 1. typu23 studií
- Obesity22 studií
- Rakovina prostaty19 studií
- Rakovina plic19 studií
- Srdeční selhání18 studií
- Melanom18 studií
- Akutní myeloidní leukemie16 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.